Cargando…

Enhanced serum concentrations of transforming growth factor-beta1 in simple fatty liver: is it really benign?

BACKGROUND: Inside the spectrum of non-alcoholic fatty liver disease, simple fatty liver is generally thought of as being "non progressive", differently from non-alcoholic steatohepatitis, which increases in severity due to the presence of apoptosis/inflammation and fibrosis. The "ben...

Descripción completa

Detalles Bibliográficos
Autores principales: Tarantino, Giovanni, Conca, Paolo, Riccio, Antonio, Tarantino, Marianna, Di Minno, Matteo N, Chianese, Domenico, Pasanisi, Fabrizio, Contaldo, Franco, Scopacasa, Francesco, Capone, Domenico
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2611972/
https://www.ncbi.nlm.nih.gov/pubmed/19038040
http://dx.doi.org/10.1186/1479-5876-6-72
_version_ 1782163105511374848
author Tarantino, Giovanni
Conca, Paolo
Riccio, Antonio
Tarantino, Marianna
Di Minno, Matteo N
Chianese, Domenico
Pasanisi, Fabrizio
Contaldo, Franco
Scopacasa, Francesco
Capone, Domenico
author_facet Tarantino, Giovanni
Conca, Paolo
Riccio, Antonio
Tarantino, Marianna
Di Minno, Matteo N
Chianese, Domenico
Pasanisi, Fabrizio
Contaldo, Franco
Scopacasa, Francesco
Capone, Domenico
author_sort Tarantino, Giovanni
collection PubMed
description BACKGROUND: Inside the spectrum of non-alcoholic fatty liver disease, simple fatty liver is generally thought of as being "non progressive", differently from non-alcoholic steatohepatitis, which increases in severity due to the presence of apoptosis/inflammation and fibrosis. The "benignity" of fatty liver is widely accepted but conceptually difficult to maintain because the mechanisms underlying this entity are the same ones that determine the more severe form. Findings provide evidence that iron overload is associated with increased liver damage and collagen deposition. Transforming growth factor-beta1 released by hepatic stellate cells during chronic liver injury plays a critical role in liver apoptosis and fibrogenesis. OBJECTIVE: To verify whether both the forms of non-alcoholic fatty liver disease were really dissimilar, evaluating the serum profile of two key parameters, indexes of severity. METHODS: A total of 123 patients (57 females) participated, forming three groups: forty five patients with fatty liver, 42 patients with non-alcoholic steatohepatitis and 36 with chronic hepatitis C. All had a biopsy-proven diagnosis. MEASUREMENTS: Serum concentrations of transforming growth factor-beta1 and ferritin. RESULTS: High concentrations of transforming growth factor-beta1 were noticed in patients suffering from both fatty liver and non-alcoholic steatohepatitis, 129.1 (45.4) versus 116.8 (42.2) ng/mL, P = 0.2; they were significantly superior to those of chronic hepatitis C patients 87.5 (39.5) ng/mL, P < 0.001. Ferritin levels were on average above normal values and similar in the three groups (P = 0.9), also when adjusted for gender (P = 0.5) and age (P = 0.3). CONCLUSION: No difference between serum concentrations of transforming growth factor-beta1 and ferritin in fatty liver and non-alcoholic steatohepatitis suggests that these forms share more common aspects, regarding their progression, than previously thought.
format Text
id pubmed-2611972
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-26119722008-12-30 Enhanced serum concentrations of transforming growth factor-beta1 in simple fatty liver: is it really benign? Tarantino, Giovanni Conca, Paolo Riccio, Antonio Tarantino, Marianna Di Minno, Matteo N Chianese, Domenico Pasanisi, Fabrizio Contaldo, Franco Scopacasa, Francesco Capone, Domenico J Transl Med Research BACKGROUND: Inside the spectrum of non-alcoholic fatty liver disease, simple fatty liver is generally thought of as being "non progressive", differently from non-alcoholic steatohepatitis, which increases in severity due to the presence of apoptosis/inflammation and fibrosis. The "benignity" of fatty liver is widely accepted but conceptually difficult to maintain because the mechanisms underlying this entity are the same ones that determine the more severe form. Findings provide evidence that iron overload is associated with increased liver damage and collagen deposition. Transforming growth factor-beta1 released by hepatic stellate cells during chronic liver injury plays a critical role in liver apoptosis and fibrogenesis. OBJECTIVE: To verify whether both the forms of non-alcoholic fatty liver disease were really dissimilar, evaluating the serum profile of two key parameters, indexes of severity. METHODS: A total of 123 patients (57 females) participated, forming three groups: forty five patients with fatty liver, 42 patients with non-alcoholic steatohepatitis and 36 with chronic hepatitis C. All had a biopsy-proven diagnosis. MEASUREMENTS: Serum concentrations of transforming growth factor-beta1 and ferritin. RESULTS: High concentrations of transforming growth factor-beta1 were noticed in patients suffering from both fatty liver and non-alcoholic steatohepatitis, 129.1 (45.4) versus 116.8 (42.2) ng/mL, P = 0.2; they were significantly superior to those of chronic hepatitis C patients 87.5 (39.5) ng/mL, P < 0.001. Ferritin levels were on average above normal values and similar in the three groups (P = 0.9), also when adjusted for gender (P = 0.5) and age (P = 0.3). CONCLUSION: No difference between serum concentrations of transforming growth factor-beta1 and ferritin in fatty liver and non-alcoholic steatohepatitis suggests that these forms share more common aspects, regarding their progression, than previously thought. BioMed Central 2008-11-27 /pmc/articles/PMC2611972/ /pubmed/19038040 http://dx.doi.org/10.1186/1479-5876-6-72 Text en Copyright © 2008 Tarantino et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Tarantino, Giovanni
Conca, Paolo
Riccio, Antonio
Tarantino, Marianna
Di Minno, Matteo N
Chianese, Domenico
Pasanisi, Fabrizio
Contaldo, Franco
Scopacasa, Francesco
Capone, Domenico
Enhanced serum concentrations of transforming growth factor-beta1 in simple fatty liver: is it really benign?
title Enhanced serum concentrations of transforming growth factor-beta1 in simple fatty liver: is it really benign?
title_full Enhanced serum concentrations of transforming growth factor-beta1 in simple fatty liver: is it really benign?
title_fullStr Enhanced serum concentrations of transforming growth factor-beta1 in simple fatty liver: is it really benign?
title_full_unstemmed Enhanced serum concentrations of transforming growth factor-beta1 in simple fatty liver: is it really benign?
title_short Enhanced serum concentrations of transforming growth factor-beta1 in simple fatty liver: is it really benign?
title_sort enhanced serum concentrations of transforming growth factor-beta1 in simple fatty liver: is it really benign?
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2611972/
https://www.ncbi.nlm.nih.gov/pubmed/19038040
http://dx.doi.org/10.1186/1479-5876-6-72
work_keys_str_mv AT tarantinogiovanni enhancedserumconcentrationsoftransforminggrowthfactorbeta1insimplefattyliverisitreallybenign
AT concapaolo enhancedserumconcentrationsoftransforminggrowthfactorbeta1insimplefattyliverisitreallybenign
AT riccioantonio enhancedserumconcentrationsoftransforminggrowthfactorbeta1insimplefattyliverisitreallybenign
AT tarantinomarianna enhancedserumconcentrationsoftransforminggrowthfactorbeta1insimplefattyliverisitreallybenign
AT diminnomatteon enhancedserumconcentrationsoftransforminggrowthfactorbeta1insimplefattyliverisitreallybenign
AT chianesedomenico enhancedserumconcentrationsoftransforminggrowthfactorbeta1insimplefattyliverisitreallybenign
AT pasanisifabrizio enhancedserumconcentrationsoftransforminggrowthfactorbeta1insimplefattyliverisitreallybenign
AT contaldofranco enhancedserumconcentrationsoftransforminggrowthfactorbeta1insimplefattyliverisitreallybenign
AT scopacasafrancesco enhancedserumconcentrationsoftransforminggrowthfactorbeta1insimplefattyliverisitreallybenign
AT caponedomenico enhancedserumconcentrationsoftransforminggrowthfactorbeta1insimplefattyliverisitreallybenign